Search Results 2521-2530 of 20290 for Receptor

1. Enemy of My Enemy - Mayo Clinic News Network

   Cancer cells also frequently overexpress receptors that viruses use to hack into cells, making them an even more attractive host. Nevertheless, the Mayo ...

2. A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma or non-Hodgkin Lymphoma - Mayo Clinic

   ... Receptor (CAR) T-cell therapy; Patients with a chronic condition requiring the use of systemic corticosteroids at a dose of > 10 milligram per day (mg/day) ...

3. Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients with Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

   ... receptor (RAR) alpha transcripts will be excluded; Patients must not have blastic transformation of chronic myelogenous leukemia; Patients with secondary AML ...

4. Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). - Mayo Clinic

   ... receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) fusions. Participation eligibility. Participant eligibility includes age, gender, type and ...

5. Dose-Escalation Study of cevostamab (BFCR4350A) in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) - Mayo Clinic

   Prior treatment with chimeric antigen receptor (CAR) T-cell therapy within 12 weeks before first cevostamab infusion. Known treatment-related, immune ...

6. Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) - Mayo Clinic

   Subject has taken biologics, azathioprine, methotrexate or small molecules (e.g., JAK inhibitors, S1P receptor modulators) within the 12 weeks prior to ...

7. Clinical trials - Oncology (Medical)

   This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive breast ...

8. Clinical trials - Oncology (Medical)

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

9. Clinical trials - Oncology (Medical)

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

10. Brain stimulation shows promise in treating drug addiction - Mayo Clinic News Network

    A Mayo Clinic neurosurgeon and his colleagues believe deep brain stimulation is poised to solve one of the greatest public health challenges: drug ...